Literature DB >> 18950960

Total microvessel perimeter per tumor area is a predictor of radiosensitivity in early-stage glottic carcinoma.

Shichuan Zhang1, Ryuichi Hayashi, Masato Fujii, Yasuhisa Hasegawa, Kunitoshi Yoshino, Masashi Fukayama, Atsushi Ochiai.   

Abstract

PURPOSE: To confirm that total number of microvessels per tumor area (TN/TA) and total microvessel perimeter per tumor area (TP/TA) are predictors for radiosensitivity in early-stage glottic carcinoma. METHODS AND MATERIALS: One hundred twenty consecutive patients with T1-2N0M0 glottic cancer who were treated with radical radiotherapy in three different hospitals in Japan were included in this study. Biopsy specimens from patients were immunostained with anti-CD31 antibody. The TN/TA and TP/TA of each sample were analyzed using a computer-assisted image analysis system. Patients were stratified into high and low groups according to the cut-off values derived from receiver operating characteristic curve analysis. Progression-free survival rates of the different groups were compared. The relationship of microvessel perimeter to vessel maturation was also discussed.
RESULTS: Survival analysis showed higher TP/TA to be associated significantly with longer progression-free survival, as compared with the lower-level group (p = 0.031). In multivariate analysis, both TP/TA (p = 0.037) and T stage (p < 0.001) proved to be independent predictive factors. Microvessel perimeter correlated closely with vessel maturity, which suggests that a tumor with high TP/TA contains more functional vessels and as a result contains more oxygenated and radiosensitive cells.
CONCLUSION: Assessment of TP/TA in biopsy specimens, using a computer-assisted analysis system, can predict the radiosensitivity of early-stage glottic carcinoma. High TP/TA may be a better indication for radiotherapy than for partial laryngectomy or laser excision.

Entities:  

Mesh:

Year:  2008        PMID: 18950960     DOI: 10.1016/j.ijrobp.2008.05.038

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Radiotherapy with or without chemotherapy for patients with T1-T2 glottic carcinoma: retrospective analysis.

Authors:  Naoki Hirasawa; Yoshiyuki Itoh; Shunichi Ishihara; Seiji Kubota; Junji Itoh; Yasushi Fujimoto; Tsutomu Nakashima; Shinji Naganawa
Journal:  Head Neck Oncol       Date:  2010-07-30

2.  Optimized treatment strategy of radiotherapy for early glottic squamous cell carcinomas: An initial analysis.

Authors:  Kana Kimura; Yoshiyuki Itoh; Tohru Okada; Seiji Kubota; Mariko Kawamura; Rie Nakahara; Yumi Oie; Yuka Kozai; Yuuki Takase; Hidenori Tsuzuki; Naoki Nishio; Mariko Hiramatsu; Yasushi Fujimoto; Takefumi Mizutani; Shinji Naganawa
Journal:  Nagoya J Med Sci       Date:  2017-08       Impact factor: 1.131

Review 3.  Proposal for personalized treatment of early glottic cancer with radiation therapy.

Authors:  Yoshiyuki Itoh; Tamami Ono
Journal:  Nagoya J Med Sci       Date:  2021-11       Impact factor: 1.131

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.